679 related articles for article (PubMed ID: 22226669)
1. An anti-IgE monoclonal antibody that binds to IgE on CD23 but not on high-affinity IgE.Fc receptors.
Shiung YY; Chiang CY; Chen JB; Wu PC; Hung AF; Lu DC; Pan RL; Chang TW
Immunobiology; 2012 Jul; 217(7):676-83. PubMed ID: 22226669
[TBL] [Abstract][Full Text] [Related]
2. A monoclonal anti-IgE antibody against an epitope (amino acids 367-376) in the CH3 domain inhibits IgE binding to the low affinity IgE receptor (CD23).
Chrétien I; Helm BA; Marsh PJ; Padlan EA; Wijdenes J; Banchereau J
J Immunol; 1988 Nov; 141(9):3128-34. PubMed ID: 2459242
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of human cord blood-derived mast cell responses by anti-Fc epsilon RI mAb 15/1 versus anti-IgE Omalizumab.
Mirkina I; Schweighoffer T; Kricek F
Immunol Lett; 2007 Apr; 109(2):120-8. PubMed ID: 17368811
[TBL] [Abstract][Full Text] [Related]
4. Reduction of total IgE by targeted coengagement of IgE B-cell receptor and FcγRIIb with Fc-engineered antibody.
Chu SY; Horton HM; Pong E; Leung IW; Chen H; Nguyen DH; Bautista C; Muchhal US; Bernett MJ; Moore GL; Szymkowski DE; Desjarlais JR
J Allergy Clin Immunol; 2012 Apr; 129(4):1102-15. PubMed ID: 22257644
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies specific to the alpha-subunit of the mast cell's Fc epsilon R block IgE binding and trigger histamine release.
Baniyash M; Alkalay I; Eshhar Z
J Immunol; 1987 May; 138(9):2999-3004. PubMed ID: 2437203
[TBL] [Abstract][Full Text] [Related]
6. Anti-anti-IgE idiotypic antibodies mimic IgE in their binding to the Fc epsilon receptor.
Baniyash M; Eshhar Z
Eur J Immunol; 1987 Sep; 17(9):1337-42. PubMed ID: 2443366
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of IgE binding to mast cells and basophils by monoclonal antibodies to murine IgE.
Baniyash M; Eshhar Z
Eur J Immunol; 1984 Sep; 14(9):799-807. PubMed ID: 6207029
[TBL] [Abstract][Full Text] [Related]
8. Binding the low affinity Fc epsilon R on B cells suppresses ongoing human IgE synthesis.
Sherr E; Macy E; Kimata H; Gilly M; Saxon A
J Immunol; 1989 Jan; 142(2):481-9. PubMed ID: 2521348
[TBL] [Abstract][Full Text] [Related]
9. Rat monoclonal anti-murine IgE antibody removes IgE molecules already bound to mast cells or basophilic leukemia cells, resulting in the inhibition of systemic anaphylaxis and passive cutaneous anaphylaxis.
Miyajima H; Watanabe N; Ovary Z; Okumura K; Hirano T
Int Arch Allergy Immunol; 2002 May; 128(1):24-32. PubMed ID: 12037398
[TBL] [Abstract][Full Text] [Related]
10. Low-affinity IgE receptor (FcepsilonRII)-mediated activation of human monocytes by both monomeric IgE and IgE/anti-IgE immune complex.
Ezeamuzie CI; Al-Attiyah R; Shihab PK; Al-Radwan R
Int Immunopharmacol; 2009 Aug; 9(9):1110-4. PubMed ID: 19505590
[TBL] [Abstract][Full Text] [Related]
11. Chimeric immunoglobulin E reactive with tumor-associated antigen activates human Fc epsilon RI bearing cells.
Luiten RM; Warnaar SO; Schuurman J; Pasmans SG; Latour S; Daëron M; Fleuren GJ; Litvinov SV
Hum Antibodies; 1997; 8(4):169-80. PubMed ID: 9395919
[TBL] [Abstract][Full Text] [Related]
12. CɛmX peptide-carrying HBcAg virus-like particles induced antibodies that down-regulate mIgE-B lymphocytes.
Lin CJ; Chen NY; Chen JB; Lu CS; Hung AF; Shiung YY; Wu PC; Pan RL; Chang TW
Mol Immunol; 2012 Oct; 52(3-4):190-9. PubMed ID: 22706073
[TBL] [Abstract][Full Text] [Related]
13. Accumulated immune complexes of IgE and omalizumab trap allergens in an in vitro model.
Hsu CL; Shiung YY; Lin BL; Chang HY; Chang TW
Int Immunopharmacol; 2010 Apr; 10(4):533-9. PubMed ID: 20139035
[TBL] [Abstract][Full Text] [Related]
14. Effect of anti-IgE antibodies on Fc epsilonRI-bound IgE.
Rudolf MP; Furukawa K; Miescher S; Vogel M; Kricek F; Stadler BM
J Immunol; 1996 Dec; 157(12):5646-52. PubMed ID: 8955217
[TBL] [Abstract][Full Text] [Related]
15. A high-affinity monoclonal anti-IgE antibody for depletion of IgE and IgE-bearing cells.
Laffer S; Lupinek C; Rauter I; Kneidinger M; Drescher A; Jordan JH; Krauth MT; Valent P; Kricek F; Spitzauer S; Englund H; Valenta R
Allergy; 2008 Jun; 63(6):695-702. PubMed ID: 18325077
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies specific for human IgE-producing B cells: a potential therapeutic for IgE-mediated allergic diseases.
Chang TW; Davis FM; Sun NC; Sun CR; MacGlashan DW; Hamilton RG
Biotechnology (N Y); 1990 Feb; 8(2):122-6. PubMed ID: 1369991
[TBL] [Abstract][Full Text] [Related]
17. Anti-CD23 monoclonal antibodies: comparisons of epitope specificities and modulating capacities for IgE binding and production.
Wakai M; Pasley P; Sthoeger ZM; Posnett DN; Brooks R; Hashimoto S; Chiorazzi N
Hybridoma; 1993 Feb; 12(1):25-43. PubMed ID: 7681036
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of ongoing allergic reactions using a novel anti-IgE DARPin-Fc fusion protein.
Eggel A; Buschor P; Baumann MJ; Amstutz P; Stadler BM; Vogel M
Allergy; 2011 Jul; 66(7):961-8. PubMed ID: 21272035
[TBL] [Abstract][Full Text] [Related]
19. Review: Diagnostic and therapeutic applications of rat basophilic leukemia cells.
Rashid A; Sadroddiny E; Ye HT; Vratimos A; Sabban S; Carey E; Helm B
Mol Immunol; 2012 Oct; 52(3-4):224-8. PubMed ID: 22750069
[TBL] [Abstract][Full Text] [Related]
20. Establishment of a Mouse Anti-ovalbumin IgE Monoclonal Antibody That Induces FcɛRII (CD23)-dependent Activation Without FcɛRI-Dependent Activation.
Yamaki K; Yoshino S
Monoclon Antib Immunodiagn Immunother; 2015 Dec; 34(6):423-31. PubMed ID: 26683182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
